Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Israeli Study Links GLP-1 Drugs to Rare Brain Disorder

Israeli researchers identified 15 cases of Wernicke encephalopathy among users of GLP-1 weight-loss drugs in Israel, prompting calls for further investigation. Earlier reports noted that the study, which examined nearly 196,000 patients, found the cases were disproportionately linked to semaglutide and tirzepatide, highlighting a risk of severe vitamin-B1 deficiency.

参与者

Israeli researchers semaglutide tirzepatide

地点

Israel
总体结论: 证据不足 置信度: 22%
摘要

All three claims stating that researchers or reviews identified 15 cases of Wernicke encephalopathy associated with GLP-1 receptor agonists, including semaglutide and tirzepatide, between September 11 and 13, 2026, have insufficient evidence.

登录或订阅以查看完整分析,包括声明、来源和时间线验证。

本部分包含基于外部来源的自动化断言核查,可能存在不准确之处。

文章

2026年九月15日
1 篇总计
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition
Study reveals possible link between GLP-1 weight loss drugs and rare brain condition

The Independent • 09月15日 17:45

An Israeli review of FDA adverse-event reports identified 15 instances of Wernicke encephalopathy among users of GLP-1 medications, prompting calls for further investigation.

可信度 71% 操纵 9% 中立
2026年九月13日
2 篇总计
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder
Popular GLP-1 weight-loss drugs linked to potentially deadly brain disorder

Yahoo Health • 09月13日 17:00

Researchers identified 15 reports of Wernicke encephalopathy in patients using GLP-1 receptor agonists, highlighting a possible link to vitamin B1 deficiency but noting the rarity of the condition.

可信度 68% 操纵 12% 中立
Ozempic and Wegovy may cause rare brain disorder, new study warns
Ozempic and Wegovy may cause rare brain disorder, new study warns

Fox News • 09月13日 17:00

A review of FDA reports and medical literature identified 15 cases of Wernicke encephalopathy among users of semaglutide and tirzepatide, prompting calls for further research.

可信度 68% 操纵 30% 中立
2026年九月12日
1 篇总计
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study
GLP-1-driven vitamin deficiency linked to rare brain disorder: Study

NewsNation • 09月12日 20:18

Researchers identified 15 cases of Wernicke encephalopathy in 2023-2024 among patients using GLP-1 agonists, highlighting a potential risk of severe thiamine deficiency.

可信度 72% 操纵 8% 中立
2026年九月11日
1 篇总计
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder
2 popular GLP-1 drugs linked to rare, life-threatening brain disorder

New York Post • 09月11日 16:09

Research involving nearly 196,000 patients identified 15 cases of Wernicke encephalopathy, a serious condition linked to vitamin B1 deficiency, that were disproportionately associated with semaglutide and tirzepatide.

可信度 57% 操纵 27% 中立